The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe
Preprint
Mattsson M. et al, (2023)
Identifying Patterns of Clinical Interest in Clinicians' Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review.
Journal article
MacKenna B. et al, (2022), JMIR Med Inform, 10
Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021
Journal article
Curtis HJ. et al, (2022), Eurosurveillance, 27
Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY.
Journal article
Hulme WJ. et al, (2022), BMJ, 378
Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records
Journal article
Horne EMF. et al, (2022), BMJ (Clinical research ed.), 378
Effectiveness of BNT162b2 booster doses in England: an observational study in OpenSAFELY-TPP
Preprint
Hulme W. et al, (2022)
Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform
Journal article
Tazare J. et al, (2022), Wellcome Open Research, 7, 142 - 142
Trends, variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY
Preprint
The OpenSAFELY Collaborative None. et al, (2022)
OpenSAFELY: Impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic
Journal article
Curtis HJ. et al, (2021), Open Heart, 8
Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: A cohort study from OpenSAFELY
Preprint
The OpenSAFELY Collaborative: None. et al, (2021)